CAPR
Capricor Therapeutics IncData: 2026-10-02
Quick Stats
Oct 02, 202648.5
AI Score
HOLD0.44
Volume Ratio
Nov 09, 2026
Next Earnings
14
+ve Days (30d)
15
-ve Days (30d)
CAPR Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
CAPR Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
CAPR Options - Sort by Max open Interest (near term)
4th October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CAPR Daily Out of Money Options - Sort by Max open Interest (near term)
4th October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CAPR Daily In the Money Options - Sort by Max open Interest (near term)
4th October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CAPR Most Active Options by Volume(near term)
4th October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CAPR Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CAPR Stock Summary
Last updated Oct 02, 2026
CAPR is currently trading at $8.95, positioned below its 200-day moving average of $22.8, suggesting bearish momentum. The stock has a 52-week range of $2.96 to $40.37.
Technical Analysis: The 50-day moving average stands at $8.0, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 48.591, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.514, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CAPR at 48.5/100 with a HOLD recommendation.
CAPR (Capricor Therapeutics Inc) Indicators
Last updated Oct 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 48.591 |
| CMF (20) | -0.514 |
| ROC (10) | -1.214 |
| ADX (14) | 14.741 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.169 |
| AROONOSC (14) | 14.286 |
| WILLAMS %R (14) | -68.917 |
| MFI (14) | 62.483 |
CAPR Candlestick Patterns
Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.
| Date | Pattern | Signal | 5-Day Hit Rate | Edge vs Baseline | Sample |
|---|---|---|---|---|---|
| Sep 21 | Three Inside Down (contrarian — textbook says the opposite) | Bullish | 56.9% | +3.9 pts | 8868 |
These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.
Capricor Therapeutics Inc is above the 50 Day SMA but below the 200 Day SMA — short-term strength within a longer-term downtrend (Mixed).
CAPR Moving Averages Analysis
Capricor Therapeutics Inc has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Oct 02, 2026
CAPR (Capricor Therapeutics Inc) Simple Moving Averages
Moving Averages are last updated Oct 02, 2026
| Days | MA |
|---|---|
| 10 | 8.85 |
| 20 | 8.83 |
| 30 | 8.87 |
| 50 | 8.0 |
| 100 | 16.97 |
| 200 | 22.8 |
CAPR Fundamental Analysis
| P/E (Forward) | 78.7402 |
| P/E (Trailing) | -- |
| Market Cap ($) | 519.8 million |
| Earnings/Share ($) | -2.31 |
| Net Profit Margin (%) | -- |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.4522 |
| EPS Estimate Next Year ($) | -1.4778 |
| WallStreet Target Price ($) | 27.00 |
| Most Recent Quarter |
Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.